Marotta Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$266K Buy
1,060
+19
+2% +$4.09K 0.04% 90
2026
Q1
$224K Hold
1,041
0.04% 99
2025
Q4
$238K Hold
1,041
0.04% 95
2025
Q3
$254K Buy
+1,041
New +$212K 0.05% 89
2025
Q2
Sell
-1,780
Closed -$352K 106
2025
Q1
$352K Buy
1,780
+72
+4% +$14K 0.07% 88
2024
Q4
$306K Sell
1,708
-72
-4% -$13.2K 0.06% 96
2024
Q3
$352K Sell
1,780
-54
-3% -$10.1K 0.07% 88
2024
Q2
$312K Buy
1,834
+77
+4% +$12.8K 0.06% 93
2024
Q1
$320K Hold
1,757
0.07% 90
2023
Q4
$272K Sell
1,757
-95
-5% -$13.8K 0.06% 91
2023
Q3
$276K Buy
1,852
+250
+16% +$36.7K 0.06% 94
2023
Q2
$216K Buy
+1,602
New +$235K 0.05% 102
2022
Q4
$260K Sell
1,611
-93
-5% -$14.3K 0.06% 92
2022
Q3
$229K Hold
1,704
0.06% 94
2022
Q2
$262K Buy
1,704
+93
+6% +$14.2K 0.06% 92
2022
Q1
$261K Buy
+1,611
New +$234K 0.06% 99

Other funds holding ABBV